相关实验视频
Updated: Jul 28, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.5K
对表皮质-介质细胞可塑性的治疗向方法,以对抗癌症转移
Adyasha Bijay Mishra1, Sudhansu Sekhar Nishank2
1Department of Zoology, Utkal University, Bhubaneswar, Odisha, 751004, India.
Medical oncology (Northwood, London, England)
|May 29, 2023
概括
向上皮质-介质细胞可塑性 (EMP) 提供了一种新方法来对抗癌症转移. 抑制EMP通路和转录因子的策略在临床前和临床研究中显示出有前途.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 表皮介质可塑性 (EMP) 驱动癌细胞的运动性和侵入性,对于转移至关重要.
- 癌症转移是癌症相关死亡的主要原因,需要新的治疗策略.
研究的目的:
- 审查目前针对表皮层-介质细胞可塑性 (EMP) 的治疗策略,以对抗癌症转移.
- 突出EMP向疗法的潜力,改善癌症患者的临床结果.
主要方法:
- 对针对EMP的治疗方法进行的临床前和临床研究的审查.
- 分析抑制关键信号通路 (例如TGF-β,Wnt/β-catenin,Notch) 调节EMP的策略.
- 针对转录因子 (例如,Snail,Slug,Twist) 和瘤微环境的方法的评估.
主要成果:
- 针对EMP的各种策略,包括途径和转录因子抑制,已在临床前和临床环境中证明有效.
- 向瘤微环境也显示出与EMP抑制结合的承诺.
- 目前的EMP向疗法在几项研究中已证明在抑制癌症转移方面具有有效性.
结论:
- EMP的治疗向是开发新型癌症疗法的有希望的策略.
- 进一步的研究对于优化EMP准策略和提高其临床有效性至关重要.
- 抑制EMP具有通过预防转移来减少与癌症相关的死亡率的巨大潜力.
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K

